Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Puma Biotechnology, Inc.
Scientific Title
An Open-label, Multicenter, Multinational, Phase 2 Study Exploring the Efficacy and Safety of Neratinib Therapy in Patients With Solid Tumors With Activating HER2, HER3 or EGFR Mutations or With EGFR Gene Amplification.